Figure
1. [A] Model structure of the rBBN. On the left (blue),
the nanobody that targets the antigenic determinant, on the right
(green) the one that binds the paratope of Omalizumab. [B]Purification results 12 % SDS-PAGE: (1) Ladder (2) Purification Flow
Through (3) Bispecific binanobody with a molecular weight of 35 kDa.